{"component": "definition", "props": {"groups": [{"size": 24, "samples": [{"hash": "g7NHn3rXGgM", "uri": "/contracts/g7NHn3rXGgM#initial-forecast", "label": "License and Supply Agreement (Journey Medical Corp)", "score": 32.8056144714, "published": true}, {"hash": "fzUkkD6WDoM", "uri": "/contracts/fzUkkD6WDoM#initial-forecast", "label": "License and Supply Agreement (Journey Medical Corp)", "score": 32.6687202454, "published": true}, {"hash": "aIMEoYtyTyo", "uri": "/contracts/aIMEoYtyTyo#initial-forecast", "label": "Supply and Distribution Agreement", "score": 31.3408622742, "published": true}], "snippet_links": [{"key": "section-43", "type": "clause", "offset": [25, 36]}], "snippet": "has the meaning given in Section 4.3.", "hash": "e67d755918e7f165c3ed86ff6c72eff9", "id": 1}, {"size": 21, "samples": [{"hash": "9CGuYXfYyKZ", "uri": "/contracts/9CGuYXfYyKZ#initial-forecast", "label": "Commercial Supply Agreement (ARS Pharmaceuticals, Inc.)", "score": 36.2142372131, "published": true}, {"hash": "cZYiybqILzj", "uri": "/contracts/cZYiybqILzj#initial-forecast", "label": "Manufacturing and Supply Agreement (Lantheus Medical Imaging, Inc.)", "score": 23.7378501892, "published": true}, {"hash": "iJXRGTiiOsH", "uri": "/contracts/iJXRGTiiOsH#initial-forecast", "label": "Contract Manufacturing and Supply Agreement (AbbVie Inc.)", "score": 23.6748809814, "published": true}], "snippet_links": [], "snippet": "has the meaning set forth in Section 2.2(a).", "hash": "e1d41f413344430a2438ca7904e440d9", "id": 2}, {"size": 10, "samples": [{"hash": "l56C2UjVrbA", "uri": "/contracts/l56C2UjVrbA#initial-forecast", "label": "Exclusive License and Supply Agreement (Protalix BioTherapeutics, Inc.)", "score": 36.8658447266, "published": true}, {"hash": "5HDBWSrfAs9", "uri": "/contracts/5HDBWSrfAs9#initial-forecast", "label": "Exclusive License and Supply Agreement (Protalix BioTherapeutics, Inc.)", "score": 26.9411354065, "published": true}, {"hash": "9NTXXVvP9BH", "uri": "/contracts/9NTXXVvP9BH#initial-forecast", "label": "Exclusive License and Supply Agreement (Protalix BioTherapeutics, Inc.)", "score": 26.8535251617, "published": true}], "snippet_links": [], "snippet": "shall have the meaning assigned to it in Section 5.6(a).", "hash": "08bc9b4f535169d17b6208af3ea1bd78", "id": 3}, {"size": 9, "samples": [{"hash": "lI09lhLbNJd", "uri": "/contracts/lI09lhLbNJd#initial-forecast", "label": "Supply Agreement (Reliant Pharmaceuticals, Inc.)", "score": 21.0, "published": true}, {"hash": "cCIAhf01GHy", "uri": "/contracts/cCIAhf01GHy#initial-forecast", "label": "Supply Agreement (Reliant Pharmaceuticals, Inc.)", "score": 21.0, "published": true}, {"hash": "DpTXA5hOi8", "uri": "/contracts/DpTXA5hOi8#initial-forecast", "label": "Supply Agreement (Reliant Pharmaceuticals, Inc.)", "score": 21.0, "published": true}], "snippet_links": [], "snippet": "shall have the meaning ascribed in Section 2.8(a).", "hash": "3ed548494542e9b7df01da43310b5feb", "id": 4}, {"size": 4, "samples": [{"hash": "8GnFXXNQ7cZ", "uri": "/contracts/8GnFXXNQ7cZ#initial-forecast", "label": "Facility Agreement (Vaalco Energy Inc /De/)", "score": 32.7604370117, "published": true}, {"hash": "9n6tCzUdJkw", "uri": "http://pdf.secdatabase.com/2510/0001437749-23-027850.pdf", "label": "pdf.secdatabase.com", "score": 17.6328697205, "published": false}, {"hash": "lbPLaEprGWz", "uri": "https://www.sec.gov/Archives/edgar/data/894627/000143774922019814/ex_397445.htm", "label": "Vaalco Energy Inc /De/", "score": 15.6050653458, "published": false}], "snippet_links": [{"key": "the-facility-agent", "type": "clause", "offset": [31, 49]}, {"key": "form-and-substance", "type": "clause", "offset": [57, 75]}, {"key": "pursuant-to-paragraph", "type": "clause", "offset": [96, 117]}, {"key": "schedule-2", "type": "clause", "offset": [126, 136]}, {"key": "conditions-precedent", "type": "definition", "offset": [138, 158]}], "snippet": "means the Forecast provided to the Facility Agent and in form and substance satisfactory to it, pursuant to paragraph 6(B) of Schedule 2 (Conditions Precedent);", "hash": "681d3d390feef706e9d3c90db2b74e50", "id": 5}, {"size": 4, "samples": [{"hash": "aBwlPaF8wNh", "uri": "/contracts/aBwlPaF8wNh#initial-forecast", "label": "Transitional Supply Agreement", "score": 31.3408622742, "published": true}, {"hash": "94zow6Ixrjp", "uri": "/contracts/94zow6Ixrjp#initial-forecast", "label": "Transitional Supply Agreement (Depomed Inc)", "score": 26.9603004456, "published": true}, {"hash": "eMnFH8titOi", "uri": "/contracts/eMnFH8titOi#initial-forecast", "label": "Transitional Supply Agreement (Depomed Inc)", "score": 26.3552360535, "published": true}], "snippet_links": [{"key": "section-31", "type": "definition", "offset": [36, 47]}], "snippet": "shall have the meaning set forth in Section 3.1.", "hash": "aa3030196f71cea70c07dfd6375ed673", "id": 6}, {"size": 3, "samples": [{"hash": "dLVMzhcorwJ", "uri": "/contracts/dLVMzhcorwJ#initial-forecast", "label": "Distribution, License and Supply Agreement (Focal Inc)", "score": 18.0, "published": true}, {"hash": "6lKvjMOhVTo", "uri": "/contracts/6lKvjMOhVTo#initial-forecast", "label": "Distribution, License and Supply Agreement (Focal Inc)", "score": 18.0, "published": true}, {"hash": "5Ad0lZCAUGb", "uri": "/contracts/5Ad0lZCAUGb#initial-forecast", "label": "Distribution, License and Supply Agreement (Focal Inc)", "score": 18.0, "published": true}], "snippet_links": [], "snippet": "shall have the meaning set forth in Section 7(h).", "hash": "899fbb3743f9b37fb8b8281146bd8253", "id": 7}, {"size": 3, "samples": [{"hash": "5aDBJ6SVXL5", "uri": "/contracts/5aDBJ6SVXL5#initial-forecast", "label": "License, Development, Manufacturing and Supply Agreement (Aytu Bioscience, Inc)", "score": 30.3634490967, "published": true}, {"hash": "kIA39wZfy9", "uri": "/contracts/kIA39wZfy9#initial-forecast", "label": "License, Development, Manufacturing and Supply Agreement (Aytu Bioscience, Inc)", "score": 30.1006164551, "published": true}], "snippet_links": [{"key": "section-51", "type": "clause", "offset": [29, 40]}], "snippet": "has the meaning set forth in Section 5.1.", "hash": "35e04d41cc9c73e4a7ee5ef3385bc143", "id": 8}, {"size": 2, "samples": [{"hash": "89msRnwOzZa", "uri": "/contracts/89msRnwOzZa#initial-forecast", "label": "Loan Agreement (Mevion Medical Systems, Inc.)", "score": 25.7720737457, "published": true}, {"hash": "2jaIaI9mokH", "uri": "/contracts/2jaIaI9mokH#initial-forecast", "label": "Loan Agreement (Mevion Medical Systems, Inc.)", "score": 25.6926765442, "published": true}], "snippet_links": [{"key": "by-borrower", "type": "clause", "offset": [29, 40]}, {"key": "to-lender", "type": "definition", "offset": [56, 65]}, {"key": "prior-to-the", "type": "clause", "offset": [66, 78]}, {"key": "tranche-a-funding-date", "type": "definition", "offset": [79, 101]}], "snippet": "means the forecast delivered by Borrower and acceptable to Lender prior to the Tranche A Funding Date.", "hash": "050490e2ee8e8f3a829ce5df95ee3f9e", "id": 9}, {"size": 2, "samples": [{"hash": "lXWsOzOwquu", "uri": "/contracts/lXWsOzOwquu#initial-forecast", "label": "Master Hosting Services Agreement", "score": 27.9034900665, "published": true}, {"hash": "WWOrPsnXAA", "uri": "/contracts/WWOrPsnXAA#initial-forecast", "label": "Master Hosted Services Agreement", "score": 27.0260105133, "published": true}], "snippet_links": [{"key": "end-user", "type": "definition", "offset": [6, 14]}, {"key": "number-of-sessions", "type": "clause", "offset": [65, 83]}, {"key": "services-order-term", "type": "definition", "offset": [167, 186]}], "snippet": "means End User\u2019s forecast provided to Nuance, which includes the number of Sessions/Requests projected for each month, along with any expected peaks in usage, for the Services Order Term.", "hash": "52c7c5083bab88e148745712019b1591", "id": 10}], "next_curs": "Cl0SV2oVc35sYXdpbnNpZGVyY29udHJhY3RzcjkLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIZaW5pdGlhbC1mb3JlY2FzdCMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"title": "Initial Forecast", "size": 101, "snippet": "has the meaning given in Section 4.3.", "id": "initial-forecast", "examples": ["Thereafter, ninety (90) days prior to the first business day of each subsequent calendar quarter during the Term, Pfizer shall deliver to Protalix a rolling four (4) calendar quarter forecast updating the prior forecast (together with the <strong>Initial Forecast</strong>, each a \u201cForecast\u201d), together with a Purchase Order for the first calendar quarter of such Forecast.", "The quantities of Drug Substance specified for the following quarter of such <strong>Initial Forecast</strong> shall be binding as provided in this Section 5.6 and the remaining two (2) quarters of such <strong>Initial Forecast</strong> shall be non-binding.", "Concurrent with the <strong>Initial Forecast</strong>, for the purposes of discussion and planning of Manufacturing capacity, Pfizer shall provide a non-binding forecast of its projected Drug Substance needs for the eight (8) calendar quarters following that specified in the <strong>Initial Forecast</strong> as described in Section 5.6(a) (a \u201cLong Range Forecast\u201d)."], "related": [["rolling-forecast", "Rolling Forecast", "Rolling Forecast"], ["forecast", "Forecast", "Forecast"], ["cash-flow-forecast", "Cash Flow Forecast", "Cash Flow Forecast"], ["contract-year", "Contract Year", "Contract Year"], ["forecast-gdp", "Forecast GDP", "Forecast GDP"]], "related_snippets": [], "updated": "2025-12-23T05:49:05+00:00"}, "json": true, "cursor": ""}}